These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15955671)

  • 1. Antileishmanial activity of HIV protease inhibitors.
    Savoia D; Allice T; Tovo PA
    Int J Antimicrob Agents; 2005 Jul; 26(1):92-4. PubMed ID: 15955671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp.
    Valdivieso E; Rangel A; Moreno J; Saugar JM; Cañavate C; Alvar J; Dagger F
    Exp Parasitol; 2010 Dec; 126(4):557-63. PubMed ID: 20566367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors.
    Trudel N; Garg R; Messier N; Sundar S; Ouellette M; Tremblay MJ
    J Infect Dis; 2008 Nov; 198(9):1292-9. PubMed ID: 18816190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes.
    Savoia D; Scutera S; Raimondo S; Conti S; Magliani W; Polonelli L
    Exp Parasitol; 2006 Jul; 113(3):186-92. PubMed ID: 16487518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial and antibacterial activity of a new pyrazole derivative designated 4-[2-(1-(ethylamino)-2-methyl- propyl)phenyl]-3-(4-methyphenyl)-1-phenylpyrazole.
    Dardari Z; Lemrani M; Sebban A; Bahloul A; Hassar M; Kitane S; Berrada M; Boudouma M
    Arch Pharm (Weinheim); 2006 Jun; 339(6):291-8. PubMed ID: 16619283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileishmanial activity of azithromycin against Leishmania (Leishmania) amazonensis, Leishmania (Viannia) braziliensis, and Leishmania (Leishmania) chagasi.
    de Oliveira-Silva F; de Morais-Teixeira E; Rabello A
    Am J Trop Med Hyg; 2008 May; 78(5):745-9. PubMed ID: 18458308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans.
    Blasi E; Colombari B; Orsi CF; Pinti M; Troiano L; Cossarizza A; Esposito R; Peppoloni S; Mussini C; Neglia R
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):187-95. PubMed ID: 15364103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii.
    Atzori C; Angeli E; Mainini A; Agostoni F; Micheli V; Cargnel A
    J Infect Dis; 2000 May; 181(5):1629-34. PubMed ID: 10823762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals as antimalarial agents.
    Skinner-Adams TS; McCarthy JS; Gardiner DL; Hilton PM; Andrews KT
    J Infect Dis; 2004 Dec; 190(11):1998-2000. PubMed ID: 15529265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of dicationic compounds against a North American foxhound isolate of Leishmania infantum.
    Rosypal AC; Hall JE; Bakunova S; Patrick DA; Bakunov S; Stephens CE; Kumar A; Boykin DW; Tidwell RR
    Vet Parasitol; 2007 Apr; 145(3-4):207-16. PubMed ID: 17298866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum.
    Di Giorgio C; Delmas F; Ollivier E; Elias R; Balansard G; Timon-David P
    Exp Parasitol; 2004; 106(3-4):67-74. PubMed ID: 15172213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors.
    Cassone A; De Bernardis F; Torosantucci A; Tacconelli E; Tumbarello M; Cauda R
    J Infect Dis; 1999 Aug; 180(2):448-53. PubMed ID: 10395861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.
    Vendrametto MC; Santos AO; Nakamura CV; Dias Filho BP; Cortez DA; Ueda-Nakamura T
    Parasitol Int; 2010 Jun; 59(2):154-8. PubMed ID: 20064628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum.
    Ordóñez-Gutiérrez L; Espada-Fernández R; Dea-Ayuela MA; Torrado JJ; Bolás-Fernandez F; Alunda JM
    Int J Antimicrob Agents; 2007 Oct; 30(4):325-9. PubMed ID: 17631982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-human immunodeficiency virus drugs are ineffective against Pneumocystis carinii in vitro and in vivo.
    Walzer PD; Ashbaugh A; Collins M; Cushion MT
    J Infect Dis; 2001 Nov; 184(10):1355-7. PubMed ID: 11679930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
    Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
    J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
    Piccinini M; Rinaudo MT; Anselmino A; Buccinnà B; Ramondetti C; Dematteis A; Ricotti E; Palmisano L; Mostert M; Tovo PA
    Antivir Ther; 2005; 10(2):215-23. PubMed ID: 15865215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.